Most patients with GORD face no higher risk for oesophageal cancer: study
Researchers say patients with non-erosive GORD had the same oesophageal cancer odds as general population.
A large Swedish study finds that most people with gastro-oesophageal reflux disease do not have a higher risk for developing cancer of the oesophagus.
Lead researcher Dr Dag Holmberg (PhD), of the Karolinska Institute in Stockholm, said gastro-oesophageal reflux disease (GORD) had long been thought to drive up cancer risk because of its potential to cause oesophagitis.
